Viatris Inc vs Essential Utilities Inc. Common Stock — how do they compare? Viatris Inc trades at $17.75 (market cap $20.05B), while Essential Utilities Inc. Common Stock trades at $40 (market cap $11.31B). The key difference: Viatris Inc is the larger of the two by market cap, and Essential Utilities Inc. Common Stock pays the higher dividend (3.62%). Which is the better fit depends on your goals — on Pluang, investors hold Viatris Inc for 57 Days and Essential Utilities Inc. Common Stock for 0 Days on average.
| VTRS | WTRG | |
|---|---|---|
Market Cap | $20.05B | $11.31B |
Volume | 8,682,135 | 2,459,172 |
Sector | Health | Utilities |
52-Week High | $18.27 | $42.00 |
52-Week Low | $9.98 | $36.25 |
Typical Hold Time | 57 Days | 0 Days |
Enterprise Value | $32.16B | $19.82B |
Dividend Yield | 2.75% | 3.62% |
Signals from Pluang's Aura AI — not financial advice
Viatris (VTRS) trades at $17.25, down 1.65% today, with a bullish technical signal from moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS of $0.69 exceeding expectations. Revenue remains stable around $14.3B annually, though the company posted a net loss of $3.51B in 2025. Analyst consensus is mixed with 38% buy ratings and a $22.17 price target, representing 28% upside potential.
The outlook suggests potential upside from current levels if earnings momentum continues, supported by strong cash flow generation and dividend payments. Key risks include persistent negative profit margins, high debt levels, and competitive pressures in the generic drug market. The stock appears reasonably valued with P/S of 1.36x, but the elevated P/E of 236x reflects current profitability challenges.
WTRG trades at $39.29, up 0.36% with neutral technical signals. The stock shows mixed earnings performance with two beats and one miss in recent quarters, while maintaining strong profitability margins (21.6% net income margin). Analyst consensus is bullish with a $44.50 price target, supported by ongoing acquisitions and pending merger developments with American Water.
The stock presents a stable utility investment with moderate growth potential through strategic acquisitions, though near-term earnings volatility and integration risks from the pending merger warrant caution. Current valuation at 20.15 P/E appears reasonable given the company's consistent cash flow generation and defensive sector positioning.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →Essential Utilities Inc. is a holding company for regulated water, wastewater, and natural gas utilities, operating under the Aqua and Peoples brands. It serves customers across Pennsylvania, Ohio, Texas, Illinois, North Carolina, New Jersey, Indiana, Virginia, and Kentucky.
Read more on WTRG →